---
title: 吉布提寄希望于转基因蚊子来遏制城市疟疾浪潮
date: 2024-05-23T04:00:37.046Z
description: Anopheles stephensi modified so that the biting females die are to be released across the country
tag: 

- Tag world
author: ft
---

[原文链接](https://ft.com/content/b8a1fbef-be76-4ccf-a7b8-68dbcd8fd377)

吉布提寄希望于转基因蚊子来遏制城市疟疾浪潮

## 概述：
吉布提即将释放由美国生物技术公司 Oxitec 开发，采用英国牛津大学技术的**转基因非咬人按蚊（***Anopheles stephensi**）**。这一举措旨在对抗一种威胁城市地区并阻碍非洲疟疾防治工作的入侵物种。这些经过改造的蚊子被设计为其后代中的雌性会死亡，因为只有雌性才会叮咬人类。类似的技术之前曾在巴西圣保罗成功应用过，抑制了 96% 的携带登革热病毒的蚊子。

吉布提政府急于阻止**埃及按蚊（***Anopheles stephensi**）**的传播，这种蚊子十年前从印度次大陆传入，自出现以来，该国疟疾病例急剧增加。在这种入侵物种出现之前，该国曾一度接近消灭疟疾。

Oxitec 的蚊虫是“自我限制”的，最终会消亡，不同于竞争对手的基因驱动技术（通过转基因昆虫繁殖优势来保持环境中的存在）。这次释放标志着转基因蚊子首次在东非释放，也是整个非洲大陆第二次释放。

## 一些有趣的问题：

1. Oxitec 的“自我限制”技术与基因驱动技术有何不同？其潜在优点是什么？
   - Oxitec的自我限制技术不同于基因驱动技术，因为它旨在最终消亡而不是持续存在于环境中。这种方法的优势在于减少了对意外后果或长期生态影响的担忧，因为转基因昆虫不会继续繁殖并随着时间推移在人群中传播。

2. 吉布提在实施Oxitec的基因蚊虫控制策略时可能面临哪些挑战？
   - 吉布提可能遇到的挑战包括公众对这一技术的接受度、在城市地区分发和释放转基因蚊子方面的物流问题，以及其他国家或组织出于生态影响考虑而产生的潜在阻力。此外，还需要持续监控以评估该战略的效果。

3. Oxitec的技术如何应用于其他面临类似**埃及按蚊（***Anopheles stephensi**）**挑战的非洲国家的疟疾防治？
   - 通过与各国政府、研究机构和国际组织合作，Oxitec 的技术可以适应并应用到其他正经历因 **埃及按蚊（***Anopheles stephensi**）**传播而导致的疟疾病例上升趋势的非洲国家。这将确保该策略能够在不同的生态环境和城市背景下得到适当部署、监测和评估其有效性。

---

## Summary:
Djibouti is set to release **genetically engineered non-biting Anopheles stephensi** mosquitoes developed by Oxitec, a US biotechnology company using technology from the UK's Oxford university. The goal of this initiative is to combat an invasive species that threatens urban areas and progress on tackling malaria in Africa. These modified mosquitoes are engineered so that their female progeny die off, as only females bite humans. Similar technology has previously been used successfully in São Paulo, Brazil, where it suppressed 96% of dengue-carrying mosquitoes.

Djibouti's government is desperate to stop the spread of Anopheles stephensi, which arrived from the Indian subcontinent a decade ago and has caused malaria cases in Djibouti to skyrocket since its arrival. The country had been on the verge of eliminating malaria before this invasive species appeared.

Oxitec's mosquitoes are "self-limiting" and will eventually die out, unlike a rival gene drive technology that persists in the environment as modified insects outbreed competitors. This release marks the first time genetically engineered mosquitoes have been released in East Africa and only the second time on the continent overall.

## Interesting Questions:
1. Q: How does Oxitec's "self-limiting" technology differ from gene drive technology, and what are its potential advantages?
   A: Oxitec's self-limiting technology differs from gene drive technology in that it is designed to eventually die out rather than persist in the environment. The advantage of this approach is that it reduces concerns about unintended consequences or long-term ecological impacts, as modified insects will not continue to reproduce and spread through populations over time.
   
2. Q: What challenges might Djibouti face when implementing Oxitec's genetebased mosquito control strategy?
   A: Challenges that Djibouti may encounter include public acceptance of the technology, logistical issues in distributing and releasing the modified mosquitoes across urban areas, potential resistance from other countries or organizations concerned about ecological impacts, and ens surveillance to monitor the effectiveness of this strategy.
   
3. Q: How might Oxitec's technology be applied to combat malaria in other African nations facing similar challenges with Anopheles stephensi?
   A: Oxitec's technology could potentially be adapted and implemented in other African countries experiencing a rise in malaria cases due to the spread of Anopheles stephensi. This would involve collaboration between governments, research institutions, and international organizations to ensure proper deployment, monitoring, and evaluation of the strategy's effectiveness across different ecological contexts and urban environments.

[Source Link](https://ft.com/content/b8a1fbef-be76-4ccf-a7b8-68dbcd8fd377)

